Ivermectin concentration in breastmilk of a woman with Strongyloides stercoralis and human T-lymphotropic virus-I co-infection
Section snippets
Report
Ivermectin (IVM) is a broad-spectrum anti-parasitic agent, highly active against most nematodes (including Strongyloides stercoralis), as well as ectoparasites (i.e. Sarcoptes scabiei and Pediculus spp). Moreover, it is effective in killing a number of insects, including mosquitoes (for instance Anopheles gambiae, vector of Plasmodium falciparum malaria), and inhibiting replication of several flaviviruses (Crump, 2017). For these reasons, IVM is considered a “wonder drug”, and its discovery
Ethics
The patient gave her written informed consent for the publication of this case report.
Funding
This work was supported by the Italian Ministry of Health “Fondi Ricerca corrente – Linea 2, progetto 4” to IRCCS Sacro Cuore – Don Calabria Hospital.
CRediT authorship contribution statement
Paola Rodari: Conceptualization, Investigation, Project administration, Writing - original draft. Dora Buonfrate: Writing - original draft, Writing - review & editing. Elena Pomari: Formal analysis, Methodology, Writing - review & editing. Gianluigi Lunardi: Formal analysis, Methodology, Writing - review & editing. Isabella Bon: Formal analysis, Methodology, Writing - review & editing. Zeno Bisoffi: Writing - original draft, Writing - review & editing. Andrea Angheben: Conceptualization,
Declaration of Competing Interest
The authors declare that they have no conflict of interest.
References (10)
Honoring antiparasitics: the 2015 Nobel Prize in Physiology or Medicine
Biomed. J
(2016)- et al.
Modeling drug passage into human milk
Clin. Pharmacol. Ther.
(2016) - et al.
Strong Treat 1 to 4 – Randomized phase 3 Clinical Trial of Multiple versus Single Dose Ivermectin for Strongyloides stercoralis infection
Lancet Infect. Dis.
(2019) Ivermectin: enigmatic multifaceted 'wonder' drug continues to surprise and exceed expectations
J. Antibiot.
(2017)- et al.
The effects of breastfeeding and presence of antibody to p40tax protein of human T cell lymphotropic virus type-I on mother to child transmission
Int. J. Epidemiol.
(1992)
Cited by (3)
Current pharmacotherapeutic strategies for Strongyloidiasis and the complications in its treatment
2022, Expert Opinion on PharmacotherapyIvermectin: a mini-review
2022, Clinical Toxicology